Katarzyna Szczepańska

9PUBLICATIONS
38CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2025
SERAAK2 as a Serotonin Receptor Ligand: Structural and Pharmacological In Vitro and In Vivo Evaluation.

Agnieszka A Kaczor, Agata Zięba, Tadeusz Karcz

|Dec 09, 2024
Guanidine Derivative ADS1017, a Potent Histamine H3 Receptor Antagonist with Promising Analgesic Activity and Satisfactory Safety Profile.

Tadeusz Karcz, Katarzyna Szczepańska, Szczepan Mogilski

|Aug 10, 2024
AR71, Histamine H3 Receptor Ligand-In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action).

Anna Stasiak, Ewelina Honkisz-Orzechowska, Zbigniew Gajda

|Jul 27, 2024
The Effect of KSK-94, a Dual Histamine H3 and Sigma-2 Receptor Ligand, on Adipose Tissue in a Rat Model of Developing Obesity.

Magdalena Kotańska, Monika Zadrożna, Monika Kubacka

|Mar 05, 2024
4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases.

Beata Michalska, Marek Dzięgielewski, Justyna Godyń

|Aug 12, 2023
Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands.

Katarzyna Szczepańska, Andrzej J Bojarski, Piotr Popik

Pageof 2